Activation of mutant protein kinase Cgamma leads to aberrant sequestration and impairment of its cellular function

Graeme Doran1, Kay E Davies, Kevin Talbot

  • 1MRC Functional Genetics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK.

Insights

Mutations in protein kinase Cgamma (PKCgamma) cause spinocerebellar ataxia type 14 (SCA14). Aberrant PKCgamma aggregation in early endosomes may reduce activity, leading to Purkinje cell damage in SCA14 patients.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Spinocerebellar ataxia type 14 (SCA14) is a neurodegenerative disease linked to mutations in protein kinase Cgamma (PKCgamma).
  • Understanding the molecular mechanisms underlying PKCgamma dysfunction in SCA14 is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the cellular consequences of SCA14-associated PKCgamma mutations.
  • To elucidate the mechanism by which PKCgamma mutations lead to Purkinje cell damage.

Main Methods:

  • Expression of various SCA14-associated PKCgamma mutations as fusion proteins in cultured cells.
  • Stimulation of cells using purinoceptors.
  • Immunocytochemistry using antibodies against phosphorylated PKCgamma and the early endosome marker EEA1.
  • Assessment of protein redistribution under oxidative stress conditions.

Main Results:

  • Expression of SCA14-associated PKCgamma mutations consistently induced cytoplasmic aggregate formation upon purinoceptor stimulation.
  • These aggregates co-localized with phosphorylated PKCgamma and the early endosome marker EEA1.
  • Mutant PKCgamma failed to redistribute to the cell membrane during oxidative stress, unlike wild-type protein.

Conclusions:

  • SCA14-associated PKCgamma mutations lead to aberrant sequestration of the protein within early endosomes.
  • This sequestration may impair PKCgamma function by reducing its availability and activity.
  • Reduced PKCgamma activity due to endosomal trapping is a proposed mechanism for Purkinje cell damage in SCA14.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...